STENTARELLI, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 7.243
EU - Europa 3.954
AS - Asia 3.034
SA - Sud America 428
AF - Africa 90
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 4
Totale 14.761
Nazione #
US - Stati Uniti d'America 7.110
GB - Regno Unito 2.051
SG - Singapore 926
CN - Cina 777
IT - Italia 417
SE - Svezia 368
HK - Hong Kong 341
BR - Brasile 325
VN - Vietnam 308
DE - Germania 300
FI - Finlandia 188
TR - Turchia 164
BD - Bangladesh 158
UA - Ucraina 149
RU - Federazione Russa 127
FR - Francia 125
IN - India 81
CA - Canada 73
KR - Corea 52
BG - Bulgaria 51
ID - Indonesia 39
MX - Messico 36
ZA - Sudafrica 34
IQ - Iraq 33
AR - Argentina 28
MY - Malesia 27
JP - Giappone 24
SI - Slovenia 22
NL - Olanda 20
CO - Colombia 19
EC - Ecuador 18
PL - Polonia 18
ES - Italia 17
PH - Filippine 17
BE - Belgio 16
IE - Irlanda 14
AE - Emirati Arabi Uniti 12
CL - Cile 12
PK - Pakistan 12
LT - Lituania 10
MA - Marocco 10
SA - Arabia Saudita 10
VE - Venezuela 10
EG - Egitto 9
PE - Perù 9
AT - Austria 8
CR - Costa Rica 8
RO - Romania 8
CZ - Repubblica Ceca 7
ET - Etiopia 7
JO - Giordania 7
PT - Portogallo 7
TH - Thailandia 7
TN - Tunisia 7
SK - Slovacchia (Repubblica Slovacca) 6
CH - Svizzera 5
DZ - Algeria 5
IR - Iran 5
NG - Nigeria 5
DK - Danimarca 4
EU - Europa 4
IL - Israele 4
JM - Giamaica 4
LB - Libano 4
AU - Australia 3
AZ - Azerbaigian 3
BO - Bolivia 3
GH - Ghana 3
GR - Grecia 3
NP - Nepal 3
SN - Senegal 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
KW - Kuwait 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MM - Myanmar 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
PY - Paraguay 2
TW - Taiwan 2
ZW - Zimbabwe 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
CG - Congo 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
KE - Kenya 1
KG - Kirghizistan 1
Totale 14.746
Città #
Southend 1.786
Ashburn 696
Santa Clara 652
Singapore 603
Fairfield 549
Woodbridge 465
Chandler 459
Hong Kong 340
Houston 300
San Jose 295
Jacksonville 287
Ann Arbor 248
Dearborn 241
Seattle 227
Wilmington 220
Beijing 218
Cambridge 199
Nyköping 159
London 129
New York 123
Helsinki 119
Modena 116
Los Angeles 112
Hefei 111
Izmir 104
Chicago 103
Dallas 102
Council Bluffs 92
Ho Chi Minh City 88
The Dalles 88
Princeton 70
Hanoi 67
Munich 58
Eugene 51
Seoul 51
Sofia 51
Shanghai 49
San Diego 46
Milan 43
Lauterbourg 42
São Paulo 38
Moscow 36
Salt Lake City 36
Buffalo 33
Bremen 32
Boardman 26
Redwood City 25
Chennai 22
Columbus 22
Frankfurt am Main 22
Tampa 21
Rome 20
Jakarta 19
Turku 19
Phoenix 18
Toronto 18
Atlanta 16
Johannesburg 16
Orem 16
Warsaw 15
Tokyo 14
Baghdad 13
Brooklyn 13
Da Nang 13
Dublin 13
Montreal 13
Bologna 12
Brussels 12
Falls Church 12
Halifax 12
Mexico City 12
San Francisco 12
Stockholm 12
Faenza 11
Falkenstein 11
Haiphong 11
Manchester 11
Medellín 11
Paris 11
Rio de Janeiro 11
Elk Grove Village 10
Lancaster 10
Norwalk 10
Sterling 10
Bengaluru 9
Denver 9
Guangzhou 9
Kuala Lumpur 9
Nanjing 9
Naples 9
Poplar 9
Tuscaloosa 9
Basingstoke 8
Charlotte 8
Detroit 8
Dong Ket 8
Kunming 8
Amsterdam 7
Chengdu 7
Ferrara 7
Totale 10.642
Nome #
Late presentation increases risk and costs of non-infectious comorbidities in people with HIV: An Italian cost impact study 805
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 802
A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity 469
Erectile dysfunction is more common in young to middle-aged HIV-infected men than in HIV-uninfected men. 439
Nonalcoholic Fatty Liver Disease in HIV-Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors 419
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 395
Aging with HIV vs. HIV Seroconversion at Older Age: A Diverse Population with Distinct Comorbidity Profiles 356
Low testosterone is associated with poor health status in men with human immunodeficiency virus infection: a retrospective study 340
Intact parathyroid hormone levels are associated with increased carotid intima media thickness in HIV infected patients 318
Epicardial adipose tissue and coronary artery calcium predict incident myocardial infarction and death in HIV-infected patients 316
Abstract: P784 ANTIRETROVIRAL THERAPY AND LIPODYSTROPHY AS PREDICTORS OF SUB-CLINICAL ATHEROSCLEROSIS 315
Clinical and epidemiological features of HIV/AIDS infection among migrants at first access to healthcare services as compared to Italian patients in Italy: a retrospective multicentre study, 2000-2010. 308
The natural history of HIV-associated lipodystrophy in the changing scenario of HIV infection 305
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study 305
MR quantitative biomarkers of non-alcoholic fatty liver disease: technical evolutions and future trends 303
HIV patients undergoing second generation antipsychotics show high cardiovascular disease burden 299
Body Composition changes in ageing HIV infected patients: the complex interplay between low muscle mass, lipodystrophy and osteopenia. 292
Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities. 288
MR techniques in the qualitative analysis of liver steatosis: the potential in the differentiation between steatohepatatis and steatosis 277
Prediction of hard cardiovascular events in HIV patients 276
Tenofovir accelerates bone mass loss of the lumbar spine in the first years of menopause in HIV infected women. 273
Body Mass Index and Weight Gain in Pregnant Women With HIV: A National Study in Italy 272
American College of Cardiology pooled equations and DAD algorithm to predict freedom from cardiovascular events in HIV patients 271
Full Viral Suppression, Low-Level Viremia, and Quantifiable Plasma HIV-RNA at the End of Pregnancy in HIV-Infected Women on Antiretroviral Treatment 268
Changes with menopause in the distribution of frailty index (FI) in HIV infected women. 264
Prevalence and predictors of preclinical coronary heart disease in post-menopause period 263
Combined use of waist and thigh circumference to identify high-risk,, abdominally obese HIV+ patients. 259
Multiecho MR sequences and high-resolution magic angle spinning (HRMAS)ex-vivo spectroscopy in the qualitative analysis and differentiationbetween steatohepatitis and steatosis 257
Multimorbidity and functional status assessment 254
HIV-Associated Lipodystrophy: Impact of Antiretroviral Therapy 253
ANTIRETROVIRAL THERAPY AND LIPODYSTROPHY AS PREDICTORS OF SUB-CLINICAL ATHEROSCLEROSIS 252
Metabolic alterations in HIV-infected pregnant women: moving to metabolic tailoring of antiretroviral drugs. 250
Should we screen for NAFLD/NASH in HIV patients? 250
Predictors of transitions in frailty severity and mortality among people aging with HIV 243
Vitamin D3 supplementation decreases the risk of diabetes mellitus among patients with HIV infection. 242
Non-alcoholic Fatty Liver Disease: a HR-MAS analysis 233
HIGH PREVALENCE OF VITAMIN D DEFICIENCY IN A COHORT OF HIV INFECTED PREGNANT AND NON-PREGNANT WOMEN OF CHILDBEARING AGE 223
HIGH PREVALENCE OF VITAMIN D DEFICIENCY IN A COHORT OF HIV INFECTED PREGNANT WOMEN AND ITS IMPACT ON PREGNANCY OUTCOME 216
MR techiniques in the quantitative assessment of liver steatosis 214
Two methods of measuring frailty among people aging with HIV 210
HR-MAS NMR SPECTROSCOPY FOR CHARACTERIZATION OF STEATOSIC LIVER: FAT QUANTIFICATION FOR A SPECTROSCOPIC DIFFERENTIATION BETWEEN STEATOSIS AND STEATOHEPATITIS 209
Health transitions in HIV-seropositive individulas undergoing NRTI-based and NRTI-sparing treatment strategies. 208
How do frailty mediate pathway leading to disability 201
Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011 198
Tesamorelin for the treatment of excess abdominal fat in HIV-infected individuals with lipodistrophy 188
Limited occurrence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study. 184
Impact of Antiretroviral Medications on Fasting Lipid Parameters 184
Menopause in HIV-infected women: somewhat different? 178
Limited occurence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study 166
Clinical evaluation is better than risk prediction algorithms to identify patients who need statin therapy. 166
Renal hyperfiltration and outcome in HIV-infected subjects. 162
Nucleoside reverse-transcriptase inhibitor use, cirrhosis, and end-stage liver disease in HIV-infected patients - Reply to Remtulla and Decker 161
L’epatopatia non alcolica da accumulo di grasso (NAFLD) in HIV: dallo screening al trattamento 56
null 49
Totale 14.904
Categoria #
all - tutte 50.452
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.452


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202183 0 0 0 0 0 0 0 0 0 0 0 83
2021/20221.128 46 159 99 132 19 60 48 72 119 82 160 132
2022/20231.132 118 139 91 117 139 162 9 130 136 20 30 41
2023/2024694 29 47 43 66 155 94 42 85 12 8 43 70
2024/20252.176 65 53 34 158 474 306 144 144 263 76 198 261
2025/20264.274 248 123 312 506 793 276 554 194 386 405 238 239
Totale 14.904